Progenics Pharmaceuticals, Inc. Human Resources Contracts & Agreements
21 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (2)
- Consulting Agreements (2)
- Employment Agreements (7)
- Transition Agreements (2)
- Form of Retention Bonus Agreement (Filed With SEC on March 13, 2020)
- Consulting Services Agreement, dated November 15, 2019, between the Registrant and David Mims (Filed With SEC on March 13, 2020)
- Employment Offer Letter Agreement between the Registrant and Bryce Tenbarge (Filed With SEC on March 13, 2020)
- Employment Offer Letter Agreement between the Registrant and Benedict Osorio (Filed With SEC on March 13, 2020)
- Employment Offer Letter Agreement between the Registrant and Asha Das (Filed With SEC on March 13, 2020)
- Consulting Services Agreement, dated as of March 4, 2020, by and between Progenics Pharmaceuticals, Inc. and Patrick Fabbio (Filed With SEC on March 4, 2020)
- Form of Non-Qualified Stock Option Award Agreement for Employees under the 2018 Performance Incentive Plan (Filed With SEC on November 7, 2019)
- Form of Non-Qualified Stock Option Award Agreement for Directors under the 2018 Performance Incentive Plan (Filed With SEC on November 7, 2019)
- Progenics Pharmaceuticals, Inc. 2018 Performance Incentive Plan (Filed With SEC on June 14, 2018)
- Employment Information for New Employees (Filed With SEC on March 11, 2016)
- Employment Information for New Employees (Filed With SEC on March 11, 2016)
- 2005 Stock Incentive Plan, as amended effective June 17, 2014 (Filed With SEC on June 18, 2014)
- 2005 Stock Incentive Plan, as amended, of the Registrant (Filed With SEC on June 17, 2013)
- PROGENICS PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN (As amended and effective as of June 13, 2012) (Filed With SEC on November 28, 2012)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2011)
- FIRST AMENDMENT TO TERMINATION AND TRANSITION AGREEMENT (Filed With SEC on March 15, 2011)
- TERMINATIONAND TRANSITION AGREEMENT BY ANDAMONG WYETH, ACTINGTHROUGH ITS WYETHPHARMACEUTICALS DIVISION, and WYETH-WHITEHALLPHARMACEUTICALS, INC., and WYETH-AYERSTLEDERLE, INC.,... (Filed With SEC on March 15, 2010)
- PROGENICS PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN (Filed With SEC on May 13, 2005)
- Description of Compensation Arrangement with respect to Named Executive Officers (Filed With SEC on March 16, 2005)
- Summary of Non-employee Director Compensation (Filed With SEC on March 16, 2005)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2004)
